10 Dec 2010 11:13
10th December 2010
CVS Group plc
("CVS" or the "Company")
Exercise of Share Options
CVS, one of the UK's leading providers of veterinary services, announces that on 9 December 2010, two of its directors Simon Innes (Chief Executive) and Paul Coxon (Finance Director) together with Brian Pound a director of CVS (UK) Limited (a wholly owned subsidiary of CVS Group plc) exercised options over in aggregate 194,779 ordinary shares of 0.2 pence each in the Company ("Ordinary Shares") under the 2007/2010 LTIP Option Scheme. Notification was received by the Company yesterday.
Application will be made for the new Ordinary Shares, which rank pari passu in all respects with the Company's existing ordinary shares, to be admitted to trading on AIM which is expected to occur on or about 15 December 2010.
On admission the Company's issued share capital will be 56,495,096 ordinary shares of 0.2 pence each. The total number of voting rights in the Company will be 56,495,096. This figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, the Company under the FSA's Disclosure and Transparency Rules.
The exercise of options referred to above includes the exercise of options by the following:
Name of option holder | No. of shares being allotted pursuant to exercise of option | Exercise price per share | Percentage of share capital following exercise and on admission of Ordinary Shares (including that of spouses) |
Simon Innes | 107,317 | £0.002 | 2.04% |
Paul Coxon | 53,658 | £0.002 | 0.6% |
Brian Pound | 33,804 | £0.002 | 1.6% |
Contacts:
CVS Group plc Simon Innes, Chief Executive Paul Coxon, Finance Director | 01379 644 288 |
Brewin Dolphin Matt Davis / Paul Mason/ Nikki Cooper
| 0845 213 1000 |
CVS Group (CVSG)